Know what’s
up down there.

Dr. Cohen is an OB-GYN research-scientist with over 28 years of studying the vaginal microbiome and its impact on reproductive health.

He led the first investigation to demonstrate an association between women with bacterial vaginosis and HIV, and since has been studying the vaginal microbiome in part to develop live biotherapeutic products to optimize the vaginal microbiome and improve reproductive health outcomes including the prevention of HIV acquisition.

The combined force led by Evvy to develop powerful datasets on the vaginal microbiome combined with the promise of new therapeutics creates the opportunity to significantly improve reproductive health outcomes for women in the US and around the world.

Dr. Diana Currie is a faculty member of the Providence St. Peter Family Medicine Residency department in Olympia, WA, an affiliate of the University of Washington medical school. A passionate educator, she has been teaching medical students and residents for over 25 years. Dr. Currie attended Harvard Medical School where she received an Albert Schweitzer Fellowship in pediatric and adolescent gynecology with a focus on maternal and reproductive health disparities.

A board-certified OB-GYN, she values the trust her patients place in her hands, heart and judgement—whether it is to deliver their newborn baby, as they go to sleep on the operating room table, or in the clinic to keep them healthy. She provides women with information about their body which allows them to make informed decisions that can positively impact all areas of their life.

She is also well versed in Functional Medicine and believes that every individual deserves a personalized, whole person approach in achieving their optimum health.

Dr. Goje is a Reproductive Infectious Disease Specialist and a Vulvar and Vaginal Health Specialist. She directs a vulvar and vaginal health clinic that serves as a referral center in Midwest United States. Clinically, she manages all complex vulvar and vaginal health disorders from infectious to non-infectious disorders.

Her research is focused on recurrent infectious, vulvovaginitis, and the complex interplay of vaginal health and microbiota.

Her  research pilot program focuses on looking at the microbiome of women with recurrent bacterial vaginosis (BV) after treatment with metronidazole gave her insight ( and corroborated her patients complaints) into the critical role of the microbiome if we are to have a sustained clinical cure in patients with recurrent BV.

Dr. Krapf is a board-certified OB-GYN and Vulvar and Vaginal Health Specialist.

She is the Associate Director for the Center for Vulvovaginal Disorders in Washington DC and an Associate Clinical Professor of Obstetrics and Gynecology at The George Washington University School of Medicine and Health Sciences. She is a Fellow of the International Society for the Study of Women’s Sexual Health (ISSWSH).  

Dr. Krapf is active in research and has published chapters and peer-reviewed articles on vulvodynia, vulvar lichen sclerosus, and vulvovaginitis.  

She is an Associate Editor for Sexual Medicine, as well as for the textbook Female Sexual Pain Disorders, 2nd Edition.  She is an author of When Sex Hurts: Understanding and Healing Pelvic Pain.

Currently, Dr. Manieri is Head of Research at Tia, a next-gen women’s health platform that uses digital wellness apps, brick and mortar clinics, and telehealth services to treat women’s health holistically.

Propelled by purpose, she leads research at Tia in order to bring forth the relevant clinical and scientific literature required to deliver integrated and comprehensive medical care to women. Previously, she completed her PhD under Dr. David Haig at Harvard University.

Schiebinger is a leading international expert on gender in science & technology and has addressed the United Nations, the European Parliament, the Korean National Assembly, and numerous funding agencies on that topic.

Schiebinger received her Ph.D. from Harvard University, is an elected member of the American Academy of Arts and Sciences, and the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and Guggenheim Fellowship.

Gendered Innovations harnesses the creative power of sex, gender, and intersectional analysis to enhance excellence and reproducibility in science and technology: Sex and Gender Analysis Improves Science and Engineering Nature (2019).

Momo is an entrepreneur-scientist who is obsessed with building a healthier future in which chronic diseases and cancers are covered in history books, not TV commercials.

He has used his extensive scientific expertise and business acumen to lead the development of the core Viome technologies, and their application towards healthier humanity. These technologies are enabling the transformation of the current healthcare, which focuses on symptoms management, into a completely novel preventative and curative model, where individuals can take control of their own health.

Momo obtained his PhD in Chemistry from the University of Utah, and BS in Microbiology from the University of Texas at El Paso. He is also an adjunct professor at the New Mexico Tech University.